Concepedia

Adam Brockman

AB

Statistics

Publications

16

Citations

792

H-Index

15

Active since

1994

Affiliations

University of Georgia(Current)

Millennium Engineering and Integration (United States)

Enveda Therapeutics (United States)

Adam Brockman is an author at University of Georgia specializing in analytical chemistry, mass spectrometric analysis, and mass spectrometry.

Publications per year

1994–2019

16

Publications

16

A Phase 1 Study of the Proteasome Inhibitor Bortezomib in Pediatric Patients with Refractory Leukemia: a Children's Oncology Group Study

Terzah M. Horton, Debananda Pati, Sharon E. Plon et al. · Clinical Cancer Research · 2007 · 150 citations

, , +14

Probe-Immobilized Affinity Chromatography/Mass Spectrometry

Adam Brockman, Ron Orlando · Analytical Chemistry · 1995 · 88 citations

, , +6

A Desalting Approach for MALDI-MS Using On-Probe Hydrophobic Self-Assembled Monolayers

Adam Brockman, Brian S. Dodd, Ron Orlando · Analytical Chemistry · 1997 · 84 citations

, , +16

Targeting the Somatostatin Receptor 2 with the Miniaturized Drug Conjugate, PEN-221: A Potent and Novel Therapeutic for the Treatment of Small Cell Lung Cancer

Kerry A. Whalen, Brian H. White, James M. Quinn et al. · Molecular Cancer Therapeutics · 2019 · 73 citations · Full text

, , +17

Assessing Toxicokinetic Uncertainty and Variability in Risk Prioritization

John F. Wambaugh, Barbara A. Wetmore, Caroline Ring et al. · Toxicological Sciences · 2019 · 72 citations · Full text

, , +13

1–5 of 16